Chee Khoon Lee (Chee K Lee)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Metastatic Renal Cell Carcinoma

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Antony J Mersiades, Benjamin J Solomon, Chee Khoon Lee, Michelle M Cummins, Lucille Sebastian, Mandy L Ballinger, Emily Collignon, Olivia Mh Turnbull, Sonia Yip, Rachael Lisa Morton, Chris Brown, Patrick J Wheeler, Malinda Itchins, R John Simes, Nick Pavlakis
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue. Future oncology (London, England) (2023)
Pasi A Janne, David Planchard, Kunihiko Kobayashi, Ying Cheng, Chee Khoon Lee, Natalia Valdivieso, Konstantin Laktionov, Tsung-Ying Yang, Yan Yu, Terufumi Kato, Liyan Jiang, Busayamas Chewaskulyong, Sarayut L Geater, Jean-Marc Maurel, Carlos Rojas, Toshiaki Takahashi, Libor Havel, Frances A Shepherd, Kentaro Tanaka, Dana Ghiorghiu, Neha P Amin, Elena Armenteros-Monterroso, Xiangning Huang, Ammar Ahmed Chaudhry, James Chih-Hsin Yang
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Angelina Tjokrowidjaja, Sarah J Lord, Thomas John, Craig R Lewis, Peey-Sei Kok, Ian C Marschner, Chee Khoon Lee
Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer. Cancer 128 (8) (2022)
Mengzhao Wang, James Chih-Hsin Yang, Paul L Mitchell, Jian Fang, D Ross Camidge, Weiqi Nian, Chao-Hua Chiu, Jianying Zhou, Yanqiu Zhao, Wu-Chou Su, Tsung-Ying Yang, Viola W Zhu, Michael Millward, Yun Fan, Wen-Tsung Huang, Ying Cheng, Liyan Jiang, Daniel Brungs, Lyudmila Bazhenova, Chee Khoon Lee, Bo Gao, Yan Xu, Wei-Hsun Hsu, Li Zheng, Pasi A Janne
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Cancer discovery 12 (7) (2022)
Peter Savas, Louisa L Lo, Stephen J Luen, Elizabeth F Blackley, Jason Callahan, Kate Moodie, Courtney T van Geelen, Yi-An Ko, Chen-Fang Weng, Lironne Wein, Maria João Silva, Andjelija Zivanovic Bujak, Miriam M Yeung, Sarah Ftouni, Rodney John Hicks, Prudence A Francis, Chee Khoon Lee, Sarah-Jane Dawson, Sherene Loi
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study. Cancer discovery 12 (9) (2022)
Rachel G Woodford, Deborah Di-Xin Zhou, Peey Sei Kok, Sarah Sally J Lord, Michael L Friedlander, Ian C Marschner, R John Simes, Chee Khoon Lee
The validity of progression-free survival 2 as a surrogate trial end point for overall survival. Cancer 128 (7) (2022)
Rachel G Woodford, Deborah Di-Xin Zhou, Sarah Sally J Lord, Ian C Marschner, Wendy Anne Cooper, Craig R Lewis, Thomas John, James Chih-Hsin Yang, Chee Khoon Lee
PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer. Future oncology (London, England) 18 (14) (2022)
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K Sabari, Alexander I Spira, Tsung-Ying Yang, Dong Wan Kim, Ki Hyeong Lee, Rachel E Sanborn, José Trigo, Koichi Goto, Jong-Seok Lee, James Chih-Hsin Yang, Ramaswamy Govindan, Joshua M Bauml, Pilar Garrido Lopez, Matthew G Krebs, Karen L Reckamp, John Xie, Joshua C Curtin, Nahor Haddish-Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E Knoblauch, Byoung Chul Cho
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Chee Khoon Lee, Michael L Friedlander, Angelina Tjokrowidjaja, Jonathan A Ledermann, Robert L Coleman, Mansoor R Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Ralph Bloomfield, Sandra Goble, Ping Wang, Rosalind M Glasspool, Clare L Scott, null null
Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis. Cancer 127 (14) (2021)
Angelina Tjokrowidjaja, David Goldstein, H Malcolm Hudson, Sarah Sally J Lord, Val Gebski, Stephen Clarke, Paul de Souza, Robert J Motzer, Chee Khoon Lee
The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy. Acta oncologica (Stockholm, Sweden) 59 (1) (2019)